Cytomembrane nanovaccines show therapeutic effects by mimicking tumor cells and antigen presenting cells
Cancer vaccines often fail to generate clinically relevant effects. Here, the authors generate a nanosized cytomembrane vaccine based on fusion between dendritic cells and cancer cells, and show them to activate anti-tumor immune responses via their antigen presenting and T-cell activating functions...
Enregistré dans:
Auteurs principaux: | Wen-Long Liu, Mei-Zhen Zou, Tao Liu, Jin-Yue Zeng, Xue Li, Wu-Yang Yu, Chu-Xin Li, Jing-Jie Ye, Wen Song, Jun Feng, Xian-Zheng Zhang |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Nature Portfolio
2019
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/67ae9c77ce0a4c3384f5b7c2f11709b8 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Antigen-Conjugated Silica Solid Sphere as Nanovaccine for Cancer Immunotherapy
par: Dong Y, et autres
Publié: (2020) -
Improved proliferation of antigen-specific cytolytic T lymphocytes using a multimodal nanovaccine
par: Li B, et autres
Publié: (2016) -
Anti-Tumor Efficacy of an Adjuvant Built-In Nanovaccine Based on Ubiquitinated Proteins from Tumor Cells
par: Huang F, et autres
Publié: (2020) -
Prodigiosin found in Serratia marcescens y2 initiates phototoxicity in the cytomembrane
par: Wang,Fei, et autres
Publié: (2013) -
CpG-Based Nanovaccines for Cancer Immunotherapy
par: Chen W, et autres
Publié: (2021)